Fig 1.
Study diagram.
Table 1.
Interaction between EGb and conventional drugs (n = 2,647).
Table 2.
Clinical characteristics and drug interactions of the patient group to evaluate the relationship between DDI of EGb - bleeding/coagulopathy (n = 747).
Table 3.
Association of EGb drug interactions with bleeding and abnormal coagulation tests (n = 747).